CFTR-France

Variant details:
Name	NM_000492.4:c.330C>A
Protein name	NP_000483.3:p.(Asp110Glu)
Genomic name (hg19)	chr7:g.117171009C>A UCSC
#Exon/intron	exon 4
Legacy Name	D110E
Class	disease-causing
WT sequence	TGGGAAGAATCATAGCTTCCTATGA C CCGGATAACAAGGAGGAACGCTCTA
Mutant sequence	TGGGAAGAATCATAGCTTCCTATGA A CCGGATAACAAGGAGGAACGCTCTA

Other databases:
		dbSNP rs397508537


Reference	PMID	Splicing	mRNA level	Maturation	Localization	Channel fonction (Cl-)	Bicarbonate
Van Goor et al, 2014	23891399		✓	✓		✓

« ✓ » indicates the type of analysis performed and not the results

clinical and functional data are provided by Vertex

No patient found in CFTR-NGS catalogue

2 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS	2
CF	2

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

Detailed genotypes:
Phenotype	Patient ID	Variant status	Additional variants
CF	733	heterozygote	CF-causing- Undef
CF	5462	heterozygote	CF-causing- Undef

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

CFTR variants are clustered into five groups:

CF-causing: when in trans with another CF-causing mutation, will result in CF.
CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
VUS (Variant of unknown clinical significance): unclassified because of insufficient data.

Go to